# VTEU: Phase II Influenza Vaccine Trial

> **NIH NIH N01** · BAYLOR COLLEGE OF MEDICINE · 2021 · $87,205

## Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases.  In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

## Key facts

- **NIH application ID:** 10471743
- **Project number:** 272201300015I-P00008-27200007-1
- **Recipient organization:** BAYLOR COLLEGE OF MEDICINE
- **Principal Investigator:** WENDY KEITEL
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $87,205
- **Award type:** —
- **Project period:** 2016-01-15 → 2021-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10471743

## Citation

> US National Institutes of Health, RePORTER application 10471743, VTEU: Phase II Influenza Vaccine Trial (272201300015I-P00008-27200007-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10471743. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*